• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放化疗后肌肉流失作为局部晚期宫颈癌远处转移失败的生物标志物

Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer.

作者信息

Lee Jie, Lin Jhen-Bin, Wu Meng-Hao, Chang Chih-Long, Jan Ya-Ting, Chen Yu-Jen

机构信息

Department of Radiation Oncology, MacKay Memorial Hospital, Taipei 104215, Taiwan.

Department of Medicine, MacKay Medical College, Taipei 252005, Taiwan.

出版信息

Cancers (Basel). 2020 Mar 5;12(3):595. doi: 10.3390/cancers12030595.

DOI:10.3390/cancers12030595
PMID:32150938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7139727/
Abstract

This study aimed to evaluate whether computed tomography (CT)-based muscle measurement predicts distant failure in patients with locally advanced cervical cancer (LACC). Data from 278 patients with LACC who underwent chemoradiation therapy (CCRT) between 2004 and 2017 were analysed. Changes in the skeletal muscle index (SMI), skeletal muscle density, and total adipose tissue index during CCRT were calculated from CT images taken at the baseline and after CCRT. The predictive capability of CT-based muscle measurement for distant failure was evaluated using Cox proportional hazards regression, Harrell's concordance index (C-index), and time-dependent receiver operating characteristic curves. SMI loss ≥ 5% was independently associated with worse distant recurrence-free survival (DRFS) (HR: 6.31, 95% CI: 3.18-12.53; < 0.001). The addition of muscle change to clinical models, including International Federation of Gynaecology and Obstetrics (FIGO) stage, lymph nodes, pathology, and squamous cell carcinoma-antigen, achieved higher C-indices (0.824 vs. 0.756; < 0.001). Models including muscle change had superior C-indices than those including weight change (0.824 vs. 0.758; < 0.001). The area under the curve for predicting 3-year DRFS was the highest for the muscle-loss model (0.802, muscle-loss model; 0.635, clinical model; and 0.646, weight-loss model). Our study demonstrated that muscle loss after CCRT was independently associated with worse DRFS and that integrating muscle loss into models including classical prognostic factors improved the prediction of distant failure.

摘要

本研究旨在评估基于计算机断层扫描(CT)的肌肉测量能否预测局部晚期宫颈癌(LACC)患者的远处失败情况。分析了2004年至2017年间接受放化疗(CCRT)的278例LACC患者的数据。根据基线和CCRT后拍摄的CT图像计算CCRT期间骨骼肌指数(SMI)、骨骼肌密度和总脂肪组织指数的变化。使用Cox比例风险回归、Harrell一致性指数(C指数)和时间依赖性受试者工作特征曲线评估基于CT的肌肉测量对远处失败的预测能力。SMI损失≥5%与较差的远处无复发生存期(DRFS)独立相关(HR:6.31,95%CI:3.18 - 12.53;<0.001)。将肌肉变化纳入临床模型,包括国际妇产科联合会(FIGO)分期、淋巴结、病理和鳞状细胞癌抗原,可获得更高的C指数(0.824对0.756;<0.001)。包括肌肉变化的模型比包括体重变化的模型具有更高的C指数(0.824对0.758;<0.001)。肌肉损失模型预测3年DRFS的曲线下面积最高(0.802,肌肉损失模型;0.635,临床模型;0.646,体重减轻模型)。我们的研究表明,CCRT后肌肉损失与较差的DRFS独立相关,并且将肌肉损失纳入包括经典预后因素的模型中可改善对远处失败的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/ecb20fff148c/cancers-12-00595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/7075c7c3bb53/cancers-12-00595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/4916ef4d7fdf/cancers-12-00595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/c407679f9c32/cancers-12-00595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/06fae07cfc93/cancers-12-00595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/82156e6e7605/cancers-12-00595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/ecb20fff148c/cancers-12-00595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/7075c7c3bb53/cancers-12-00595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/4916ef4d7fdf/cancers-12-00595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/c407679f9c32/cancers-12-00595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/06fae07cfc93/cancers-12-00595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/82156e6e7605/cancers-12-00595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/7139727/ecb20fff148c/cancers-12-00595-g006.jpg

相似文献

1
Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer.放化疗后肌肉流失作为局部晚期宫颈癌远处转移失败的生物标志物
Cancers (Basel). 2020 Mar 5;12(3):595. doi: 10.3390/cancers12030595.
2
Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.骨骼肌肉丢失是局部晚期宫颈癌根治性放化疗后结局的影像学生物标志物。
Clin Cancer Res. 2018 Oct 15;24(20):5028-5036. doi: 10.1158/1078-0432.CCR-18-0788. Epub 2018 Jun 29.
3
[Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].[同步放化疗治疗晚期宫颈鳞状细胞癌患者远处转移的结局及预后因素]
Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):125-30.
4
Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.局部晚期宫颈癌患者接受根治性同期放化疗后总生存风险评估模型。
Gynecol Oncol. 2013 Jan;128(1):54-59. doi: 10.1016/j.ygyno.2012.09.033. Epub 2012 Oct 9.
5
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.(18)F-FDG PET/CT在接受同步放化疗的晚期子宫颈鳞状细胞癌患者中的应用:一项前瞻性随机试验的平行研究
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1812-23. doi: 10.1007/s00259-016-3384-7. Epub 2016 May 10.
6
Prognostic models for locally advanced cervical cancer: external validation of the published models.局部晚期宫颈癌的预后模型:已发表模型的外部验证
J Gynecol Oncol. 2017 Sep;28(5):e58. doi: 10.3802/jgo.2017.28.e58. Epub 2017 May 26.
7
Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.治疗前MRI最小表观扩散系数值是接受根治性放化疗的宫颈癌患者的一种潜在预后影像生物标志物。
BMC Cancer. 2016 Jul 28;16:556. doi: 10.1186/s12885-016-2619-0.
8
Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.同步放化疗治疗局部晚期宫颈癌远处复发的预测因素
Gynecol Oncol. 2008 Jan;108(1):126-9. doi: 10.1016/j.ygyno.2007.08.091. Epub 2007 Oct 23.
9
A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.一种基于人乳头瘤病毒 DNA 和肿瘤大小的风险分层新标志物,用于预测局部晚期宫颈癌的生存。
Int J Gynecol Cancer. 2019 Mar;29(3):459-465. doi: 10.1136/ijgc-2018-000095. Epub 2019 Feb 7.
10
Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.基于磁共振成像、全肿瘤表观扩散系数值和 HPV 基因分型的预测模型,用于评估接受放化疗的 IB-IV 期宫颈癌患者的预后。
Eur Radiol. 2019 Feb;29(2):556-565. doi: 10.1007/s00330-018-5651-4. Epub 2018 Jul 26.

引用本文的文献

1
The Prognostic Value of Sarcopenia in Clinical Outcomes in Cervical Cancer: A Systematic Review and Meta-Analysis.肌肉减少症对宫颈癌临床结局的预后价值:一项系统评价和荟萃分析
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13674. doi: 10.1002/jcsm.13674.
2
Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and F-FDG PET/CT parameters.骨骼肌及 F-FDG PET/CT 参数对宫颈鳞癌患者总生存及近期疗效的分析。
Sci Rep. 2024 Feb 27;14(1):4809. doi: 10.1038/s41598-024-55268-2.
3
Analysis of nutritional risk, skeletal muscle depletion, and lipid metabolism phenotype in acute radiation enteritis.

本文引用的文献

1
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.原发性减瘤手术和化疗过程中的肌肉丢失可预测晚期卵巢癌的不良预后。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):534-546. doi: 10.1002/jcsm.12524. Epub 2020 Jan 30.
2
Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.应用 CT 标准化相位测量肌肉对晚期卵巢癌患者的预后价值。
Nutrition. 2020 Apr;72:110642. doi: 10.1016/j.nut.2019.110642. Epub 2019 Nov 9.
3
Changes in Body Composition During Adjuvant FOLFOX Chemotherapy and Overall Survival in Non-Metastatic Colon Cancer.
急性放射性肠炎的营养风险、骨骼肌消耗及脂质代谢表型分析
World J Gastrointest Surg. 2023 Dec 27;15(12):2831-2843. doi: 10.4240/wjgs.v15.i12.2831.
4
Symptom clusters and characteristics of cervical cancer patients receiving concurrent chemoradiotherapy: A cross-sectional study.接受同步放化疗的宫颈癌患者的症状群及特征:一项横断面研究。
Heliyon. 2023 Nov 17;9(12):e22407. doi: 10.1016/j.heliyon.2023.e22407. eCollection 2023 Dec.
5
Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer.用于预测卵巢癌手术和辅助化疗期间骨骼肌丢失的可解释机器学习模型。
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2044-2053. doi: 10.1002/jcsm.13282. Epub 2023 Jul 12.
6
Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy.预后营养指数与接受初次肿瘤细胞减灭术和化疗的卵巢癌患者肌肉减少和生存的关系。
Support Care Cancer. 2023 Apr 14;31(5):267. doi: 10.1007/s00520-023-07719-1.
7
Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma.基于影像组学的列线图预测IB1-IIA2期宫颈癌术后营养不良的模型构建与验证
Front Nutr. 2023 Feb 3;10:1113588. doi: 10.3389/fnut.2023.1113588. eCollection 2023.
8
Prognostic significance of postoperative loss of skeletal muscle mass in patients underwent coronary artery bypass grafting.冠状动脉旁路移植术后骨骼肌质量丢失对患者的预后意义。
Front Nutr. 2022 Sep 2;9:970729. doi: 10.3389/fnut.2022.970729. eCollection 2022.
9
Relationship between muscular fitness and quality of life as well as psychological distress in radiotherapy patients with cervical cancer.宫颈癌放疗患者肌肉功能与生活质量和心理困扰的关系。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Nov 28;46(11):1260-1266. doi: 10.11817/j.issn.1672-7347.2021.210317.
10
Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer.雄激素剥夺治疗期间的肌肉损失与高危前列腺癌患者非癌症死亡风险增加相关。
Front Oncol. 2021 Sep 17;11:722652. doi: 10.3389/fonc.2021.722652. eCollection 2021.
辅助性FOLFOX化疗期间非转移性结肠癌患者身体成分的变化及总生存期
Cancers (Basel). 2019 Dec 24;12(1):60. doi: 10.3390/cancers12010060.
4
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.恶病质身体组成和炎症标志物预示着接受放化疗的局部晚期胰腺癌患者预后不良。
Cancers (Basel). 2019 Oct 26;11(11):1655. doi: 10.3390/cancers11111655.
5
Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss.关于伴有厌食和体重减轻的癌症患者纵向研究的设计和分析的述评。
J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1175-1182. doi: 10.1002/jcsm.12480. Epub 2019 Aug 20.
6
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.肌肉减少症与卵巢癌生存:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1165-1174. doi: 10.1002/jcsm.12468. Epub 2019 Aug 7.
7
Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.癌症治疗过程中肌肉放射性密度的丧失与晚期子宫内膜癌患者的不良预后相关。
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):814-826. doi: 10.1002/jcsm.12440. Epub 2019 May 15.
8
Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study.宫颈癌图像引导近距离治疗后失败模式的变化:来自 RetroEMBRACE 研究的分析。
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):895-902. doi: 10.1016/j.ijrobp.2019.03.038. Epub 2019 Mar 30.
9
Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy.同期放化疗治疗局部晚期宫颈癌患者营养状况恶化。
J Hum Nutr Diet. 2019 Aug;32(4):480-491. doi: 10.1111/jhn.12649. Epub 2019 Apr 1.
10
Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer.胰腺癌患者的肿瘤特异性和器官特异性蛋白质合成率。
J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):549-556. doi: 10.1002/jcsm.12419. Epub 2019 Mar 13.